Researchers found that post-COVID-19 condition (PCC) symptoms persist in a significant number of both SARS-CoV-2 positive and negative emergency department patients, highlighting the non-specific nature of the WHO’s PCC criteria.
AstraZeneca ponders a China pharma spinoff to protect itself from geopolitical fallout — FT
As senior government officials in the US warily look to stabilize rocky relations with China, one global pharma giant has been considering a corporate restructuring
June 21, 2023